The peripheral airways are technically challenging to assess and have been overlooked in the assessment of chronic respiratory diseases such as Asthma, in both the clinical and research space. Evidence of the importance of the small airways in Asthma is building, and small airways dysfunction is implicated in poor Asthma control, airway hyperresponsiveness, and exacerbation risk. The aim of this research was to complete comprehensive global, regional, and spatial assessments of airway function and ventilation in Asthma using physiological and MRI techniques. Specific ventilation imaging (SVI) and Phase resolved functional lung imaging (PREFUL) formed the spatial assessments. SVI uses oxygen as a contrast agent and looks at rate of change in signal to assess ventilation heterogeneity, PREFUL is a completely contrast free technique that uses Fourier decomposition to determine fractional ventilation.

The main transmission mode of the COVID-19 disease is through virus-laden aerosols and droplets generated by expiratory events, such as breathing and sneezing. Patients with respiratory diseases are typically treated with oxygenation devices in hospitals, homes, and other settings where they increase the risk of spreading the disease to caregivers and first responders. Here, I will discuss a systematic study of aerosol and droplet dispersal through the air and their final deposition on surfaces. Through laser and fluorescent imaging techniques, we measure the volumetric spatial-temporal dynamics of droplet dispersal while varying rheological properties of the mucosaliva. We then demonstrate that a standard nose and mouth mask reduces the amount of mucosaliva dispersed by a factor of at least a hundred. Our ongoing collaborations with doctors and respiratory therapists from the Baystate Medical Hospital are developing new guidelines to help mitigate disease spread in a hospital setting.